Abstract #1399269: Never Too Old for Genetics: An Unusually Late Presentation of Medullary Thyroid Cancer in MEN2A

نویسندگان

چکیده

Virtually all germline RET pathogenic variant carriers develop medullary thyroid carcinoma (MTC). If possible, thyroidectomy should be performed prophylactically, before developing MTC. We describe a patient with pheochromocytoma found to have p.Cys634Ser at age sixty years who would categorized as high risk based on genotype classification described by the American Thyroid Association and warranted prophylactic young age. A 60-year-old man history of hypothyroidism osteopenia was an adrenal mass during evaluation for kidney stones. It measured 4.1 x 3.2 3.8 cm CT scan abdomen pelvis. MRI without gadolinium revealed 4 left T2 enhancement. Diagnosis confirmed elevated levels plasma free metanephrine normetanephrine. The nodule showed avid uptake PET Gallium-68 DOTATATE scan. No noted contralateral gland or in neck. Patient underwent adrenalectomy. Surgical pathology pheochromocytoma. also had evidence primary hyperparathyroidism (pHPT). Germline genetic analysis c.1900T >A(p.Cys634Ser) confirming diagnosis multiple endocrine neoplasia type 2A (MEN2A). Calcitonin level mildly 27.8 pg/ml. Subsequently, total thyroidectomy, subtotal parathyroidectomy bilateral central neck dissection. multifocal MTC, diffuse C-cell hyperplasia, foci papillary microcarcinoma. Immunohistochemistry calcitonin hyperplasia. doing well postoperative follow up downtrended < 2 Nearly patients MEN2A either hyperplasia (CCH) approximately 50% 20-30% pHPT. Age-related penetrance CCH hMTC is mutation dependent. Peak incidence index third decade life MEN2A. Our presented sixth life. decided pursue testing. DOTATE did not show only elevated. However, there known complete MTC syndrome, dissection results surgical presence This case highlights importance considering syndromes even present older ages challenges classic genotype-phenotype correlation

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Never too old to fight breast cancer

RATIONALE Breast cancer is the most common cancer affecting females worldwide and its lifetime risk increases with age. Human epidermal growth factor receptor gene-2 (HER-2) positive breast cancer represents about 20% of all breast cancers, 1 out of 10 is diagnosed in women over 70 years of age. It tends to be more aggressive and to spread more quickly than other subtypes, but the introduction ...

متن کامل

Ondine's curse--never too late.

a normal life span. It has recently been shown that CCHS confers risk for adverse neurocognitive outcome [3]. Visuoperceptual reasoning and clerical/ visuographic speed appear particularly vulnerable. In this issue of IMAJ, Cohen-Cymberknoh and colleagues [4] present an interesting and unusual case of a 12 year old girl with late-onset CCHS that was suspected and diagnosed only after she failed...

متن کامل

Genetic and Epigenetic of Medullary Thyroid Cancer

Medullary thyroid carcinoma (MTC) is an infrequent calcitonin-producing neuroendocrine tumor that initiates from the parafollicular C cells of the thyroid gland. Several genetic and epigenetic alterations are collaterally responsible for medullary thyroid carcinogenesis. In this review article, we shed light on all the genetic and epigenetic hallmarks of MTC. From the genetic perspective, RET, ...

متن کامل

Medullary Thyroid Cancer: A Review

Thyroid cancer is a malignancy of the thyroid parenchymal cells. There are four main types of thyroid cancer: papillary thyroid cancer (PTC), follicular thyroid cancer (FTC), anaplastic thyroid carcinoma (ATC), and Medullary thyroid carcinoma (MTC). Medullary thyroid cancer (MTC) is a rare neuroendocrine tumor of the thyroid gland derived from parafollicular C-cells that produce calcitonin (CT...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Endocrine Practice

سال: 2023

ISSN: ['1530-891X', '1934-2403']

DOI: https://doi.org/10.1016/j.eprac.2023.03.094